Among the many breast neoplasm variants, triple-negative breast cancer (TNBC) is characterized by a lack of expressiveness in the estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) (1). This evidence concerns the gene ESR1 and triple-negative breast carcinoma.